BACKGROUND: Diabetes mellitus is increasing in men of reproductive age. 1 Despite this, the prevalence of diabetes in men attending UK infertility clinics 2 is unknown. Furthermore, studies examining its effects on sperm fertility 3 potential have been limited to conventional semen analysis. 4
Road, Belfast, BT12 6BJ . 10
Tel: +44 (0) 28 9063 5060 11
Fax: +44 (0) 28 9032 8247 12 13 Diabetes mellitus (DM) represents one of the greatest threats to modern 2 global health. Its incidence is rising rapidly. In the year 2000, 177 million 3 people were affected by diabetes worldwide but by 2025 this figure is 4 projected to rise to over 300 million (World Health Organization 2002) . Factors 5 such as obesity, population growth and ageing are thought to be largely 6 responsible (Wild et al. 2004) . 7
The vast majority (>90%) of patients with type-1 diabetes are diagnosed 8 before the age of 30 (Williams et al. 2004 ). This type of diabetes is rising by 9 3% per annum in European children, with an increasing number being 10 diagnosed in early childhood (EURODIAB 2000) . Over the next 10 years this 11 will result in a 50% increase in prevalence, making diabetes the commonest 12 endocrine disorder in children (Silink 2002) . 13
Type 2 diabetes, classically a late onset condition, is now being 14 recognised much more frequently in younger age groups. In the United States 15 alone, it is estimated to account for up to 76% of diabetes in the teenage 16 years (Liese et al. 2006) . As a consequence of these epidemiological changes 17 for both type 1 & 2 diabetes many more men will be affected prior to and 18 during their reproductive years. 19
Diabetes mellitus may affect male reproductive function at multiple levels 20 as a consequence of its effects on the endocrine control of spermatogenesis, 21 spermatogenesis itself or by impairing penile erection and ejaculation (Sexton 22 et al. 1997) . There are a number of reports in the literature examining the 23 effects of diabetes on the endocrine control of spermatogenesis (Daubresse 24 et al. 1978; Handelsman et al. 1985; Dinulovic et al. 1990a; Garcia-Diez et al. 1 1991; Baccetti et al. 2002; Ballester et al. 2004 ). However, the results of these 2 studies have been conflicting and the reported abnormalities are unlikely to 3 impair reproductive function significantly in isolation (Sexton et al. 1997) . 4
Diabetes is, however, a well-recognised cause of male sexual dysfunction, 5 which in itself may contribute to sub-fertility. Erectile dysfunction is more 6 common in diabetic men (McCulloch et al. 1980; Feldman et al. 1994; Glenn 7 et al. 2003 ) and occurs at an earlier age than in non-diabetic men (Klein et al. 8 1996) . In addition, up to a third of diabetic men are estimated to suffer from 9 ejaculatory disorders (Dunsmuir et al. 1996) . 10
Studies of sperm quality in diabetes have been limited to light 11 microscopic assessment of conventional semen parameters (semen volume, 12 sperm count, motility and morphology). Classic semen analysis is now 13 recognised to be of limited value in the determination of fertility status (Jequier 14 2005) unless there are more extreme abnormalities such as severe 15 oligoasthenoteratozoospermia or azoospermia. The paucity of studies 16 addressing the effects of DM on human male reproductive function and the 17 conflicting nature of existing data have resulted in a distinct lack of consensus 18 in the current literature as to the extent of the problem. 19
Data from animal models strongly suggest that DM impairs male fertility. 20
Numerous studies have demonstrated a marked reduction in fecundity when 21 male animals are diabetic (Frenkel et al. 1978; Murray et al. 1983; Cameron 22 et al. 1990; Ballester et al. 2004; Scarano et al. 2006) , as well as an 23 impairment of sperm quality (Amaral et al. 2006; Scarano et al. 2006 ). If 24 similar effects exist in the context of human male reproduction, the rising rates 25 of diabetes may well pose a significant problem to human fertility. The 1 potential impact of the increase in diabetes in young men and its effect on 2 their reproductive health have received comparatively little attention, to date. 3
To our knowledge, at a population rather than an individual level, there 4 has been no comparison of diabetic and non-diabetic male fecundity. 5
However, there is evidence to suggest a higher prevalence of infertility in 6 diabetic men (Sexton et al. 1997) and an increase in adverse reproductive 7 outcomes such as miscarriage in their partners (Babbott et al. 1958) . In view 8 of this, it is essential that a logical and rigorous scientific analysis of the 9 effects of diabetes on male reproductive function be performed. 10
An alternative approach to the light microscopic assessment of male 11 fertility is the assessment of sperm nuclear DNA (nDNA) or mitochondrial 12 DNA (mtDNA) quality. These have been shown to be 'proxy' indicators of 13 male fertility status (Agarwal et al. 2003; O'Brien et al. 2005; St John et al. 14 2005) . Together, an assessment of sperm nDNA fragmentation and mtDNA 15 deletion number and size, has been shown to have prognostic value in 16 assisted reproductive outcomes (Lewis et al. 2004) . To our knowledge, this 17 paper is the first to compare DNA quality in sperm from diabetic and non-18 diabetic men. 19
The aim of this study was to compare male fertility potential by 20 conventional and molecular techniques in diabetic and non-diabetic subjects. Male type-1 diabetics aged between 18 and 60, attending the Regional 12
Centre for Endocrinology and Diabetes at the Royal Victoria Hospital, Belfast, 13
for routine assessment of their diabetes, were invited to participate in this 14 study (Mean age 34±2; n=27). Men attending the Queen's University of 15
Belfast Andrology Laboratory at the Regional Fertility Centre, Royal Maternity 16
Hospital, Belfast, for semen analysis as part of routine infertility investigations 17 (Mean age 33±1; n=29) were employed as a control group. A venous blood 18 sample was taken at the time of semen analysis for the measurement of 19
Glycosylated Haemaglobin (HbA1c) in order to assess recent glycaemic 20 control. All subjects gave written informed consent for participation in this 21 study and the project was approved by the Office for Research Ethics 22
Committees in Northern Ireland (ORECNI) and the Royal Group Hospitals 1
Trust Clinical Governance committee. 2 Semen samples were obtained after a recommended 2-5 days of sexual 3 abstinence. All samples were subjected to a conventional light microscopic 4 semen analysis to determine liquefaction, semen volume, sperm 5 concentration and motility according to WHO recommendations (World Health 6
Organization 1999). Sperm morphology was assessed according to 7
Tygerberg Strict Criteria (Kruger et al. 1988 ). Semen analysis was performed 8 within 1 hour of ejaculation, following a period of incubation at 37°C to allow 9 for liquefaction. The remaining semen was divided into aliquots and incubated 10 at 37°C in preparation for further analysis by COMET assay. 11
Aliquots of semen (containing 3-5 million sperm) from each subject were 12 diluted in cryovials with Sperm freeze, (Fertipro N.V., 8370 Beernem, 13 Belgium) in a ratio of 1:0.7, then plunge frozen in liquid nitrogen, following 14 static phase vapour cooling, for a period of 15 minutes. DNA from these 15 samples was subsequently extracted and used for mtDNA assessment by 16 Long-PCR as described below. 17
Assessment of sperm nDNA fragmentation by modified
18 alkaline single cell gel electrophoresis (COMET) assay. 19 Nuclear DNA fragmentation was assessed using an alkaline single cell 20 gel electrophoresis (COMET) assay as previously modified by our group 21 (Hughes et al. 1997; Donnelly et al. 1999) . Briefly, aliquots of neat semen 22
were adjusted with PureSperm ® wash (Nidacon International AB, Mölndal, 23 Sweden) to give a sperm concentration of 6 x 10 6 mL -1 . Those semen samples 24 with an initial concentration less than this were used without dilution. 1
Following the initial preparation of the sperm sample, all subsequent steps 2 were carried out in a climate controlled room (18°C) under yellow light, to 3 prevent induced DNA damage. 4
Embedding of Sperm in Agarose Gel 5
Fully frosted microscope slides (Surgipath Europe, Peterborough, UK), 6
were heated gently, coated with 100µl of 0.5% normal melting point agarose 7
(Sigma-Aldrich, Poole, UK) in phosphate buffered saline (Sigma), kept at 8 45°C and immediately covered with a glass coverslip (22 x 50 mm). Slides 9 were left at ambient temperature (18°C) to allow the agarose to solidify. The 10 coverslips were removed, and 10µl of diluted semen (6 x 10 6 mL -1 ) was mixed 11 with 75µl of 0.5% low melting point agarose (Sigma) at 37°C. This cell 12 suspension was pipetted over the first layer of gel, covered with a glass 13 coverslip and allowed to solidify at ambient temperature. 14
Lysing of Cells and Decondensation of DNA 15
Coverslips were removed and the slides immersed in a Coplin jar 16 containing 22.5mls of fresh lysis solution (2.5M NaCl, 100mM 17
Ethylenediamene tetraacetic [EDTA] and 10mM Tris (pH10), with 1% Triton X-18 100 (Sigma) added just prior to use), for 1 hour at 4°C. Subsequently 10mM 19 dithiothreitol [DTT] (Sigma) was added for a further 30 minutes at 4°C, 20 followed by 4mM lithium diiodosalicylate [LIS] (Sigma) at ambient temperature 21 for 90 minutes. 22
Unwinding of DNA 23
Slides were removed from the lysis solution and drained of any residual 24 fluid. Fresh alkaline electrophoresis solution was prepared (300mM NaOH, 25 1mM EDTA; Sigma) and poured into a horizontal gel electrophoresis tank. 1
The agarose coated slides were placed side by side in the tank, with the 2 labelled end facing the cathode for 20 minutes, allowing the exposed DNA to 3 unwind. 4
Separation of DNA Fragments by Electrophoresis 5
Electrophoresis was carried out for 10 minutes at 25V, with the current 6 adjusted to 300mA, by the addition or removal of buffer from the tank. 7
Following this, slides were removed from the tank, drained and flooded with 8 three changes of neutralisation buffer (0.4M Tris; pH 7.5; Sigma), removing 9 any residual alkali or detergents that may interfere with staining. Slides were 10 stained with 50µl of 20µg/ml ethidium bromide (Sigma), covered with a glass 11 coverslip and stored in a humidified container in darkness at 4°C, until 12 analysis. 13
Image Analysis 14
Slides were viewed on a Nikon E600 epifluorescence microscope 15 (Nikon, Tokyo, Japan) equipped with an excitation filter of 515-560 nm from a 16 100W mercury lamp and a barrier filter of 590nm. The proportion of 17 fragmented DNA was determined using an image analysis system (Komet 18 3.1, Kinetic Imaging, Nottingham, United Kingdom) to analyse 50 sperm per 19 slide (Hughes et al. 1997) . 20
Assessment of Sperm Mitochondrial DNA Deletions by Long-
DNA was isolated from sperm samples using a Puregene DNA isolation 4 kit (Gentra Systems, Minneapolis, MN). Briefly, samples previously frozen in 5 liquid nitrogen were allowed to defrost at room temperature and then 6 centrifuged at 16000g for 1 minute to pellet cells. The supernatant was 7 removed and 300µl of cell Lysis Solution (Gentra) added and pipette mixed. 8
Following this, 12µl of 1M DTT (Sigma) and 1.5µl of 20mgmL -1 Proteinase k 9 (Sigma) were added. Samples were inverted 25 times and incubated at 55°C 10 overnight to allow complete lysis of the cells. 11
After cooling to room temperature, 1.5µl of RNAse A solution (Gentra) 12 was added to the cell lysate and incubated for 1 hour at 37°C. Samples were 13 again allowed to cool to room temperature prior to adding 100µl of Protein 14
Precipitation Solution (Gentra). This was placed on ice for 5 minutes and then 15 centrifuged at 16000g for 4 minutes to pellet the precipitated proteins. DNA 16 was precipitated by pouring the supernatant containing the DNA into an 17
Eppendorf tube containing 300µl of 100% isopropanol (Sigma) and inverting 18 50 times. Following centrifugation at 16000g for 1 minute and removal of 19 supernatant, the tube was inverted on absorbent paper to drain for 15 20 minutes. The DNA pellet was subsequently washed with 300µl 70% Ethanol 21 (Sigma) by inversion several times before centrifugation at 16000g for 1 22 minute. The supernatant was removed and the DNA pellet allowed to dry. 23 Following this, DNA was re-hydrated by adding 50µl of DNA Hydration 1 Solution (Gentra) to the tube and incubating for 1 hour at 65°C. 2 DNA quantitation was performed on each sample using a 3 nanospectrophotometer (NanoDrop ND-1000 v 3.0.0, NanoDrop 4 Technologies Rockland USA) at a wavelength of 260nm. This was first 5 calibrated using ultra pure water (DEPC Water, Gibco, Invitrogen, Paisley, 6 UK). Extracted DNA was stored at 4°C prior to use for assessment of mtDNA. 7
Long-Polymerase Chain Reaction amplification 8
L-PCR amplification of mtDNA was performed in 50µl volumes using 9
Bio-X-Act DNA polymerase (Bioline, London, UK) and a Hyabid touchdown 10 thermal cycling system (Hyabid Ltd, Middlesex, UK). Reaction mixtures 11
contained 1 x Optiform buffer (Bioline), 1.5mM MgCl 2 , 0.25mM dNTPs, 500ng 12 DNA template, 2U of Bio-X-act (Bioline) and 0.5µM of each primer (D6: 5'-13
TCT AGA GCC CAC TGT AAA G-3', L strand sequence, position 8286-8304 14 and R10: 5'-AGT GCA TAC CGC CAA AAG A-3', L strand sequence, position 15 421-403) (Lestienne et al. 1997) . In brief, initial denaturation was performed at 16 94°C for 2 minutes, followed by 34 cycles of denaturation at 94°C for 10 17 seconds, annealing at 52°C for 30 seconds and extension at 68°C for 10 18 minutes. The 'Semi-hot' technique was used, in which tubes containing all of 19 the reaction components were placed in the thermal cycler at the beginning of 20 the denaturation phase. Negative and positive controls were included in each 21 set of reactions using primers for -Actin. L-PCR was repeated in duplicate 22 samples to ensure reproducibility and identical deletions were found. Reaction 23 products were separated by electrophoresis in a 0.8% agarose gel (Sigma) 24 made with Tris-Acetate-EDTA buffer (10X TAE Buffer; Gibco-BRL, Life 25
Technologies, Paisley, United Kingdom), containing 1µgmL -1 ethidium 1 bromide (Sigma). A voltage of 120V was applied for 60 minutes. Following 2 electrophoresis, mtDNA deletions were visualised using an ultraviolet bio-3 imaging system (EC3 Imaging System, UVP Ltd, Cambridge, UK). 4
The number of mtDNA deletions was calculated by counting the total 5 number of bands detected for each subject from L-PCR products. The 6 deletion size was calculated by comparing its position on the gel to an 7 adjacent molecular weight ladder (HyperLadder I, Bioline). The mean deletion 8 size was calculated by dividing the sum of all deletion sizes by the total 9 number of deletions. 10
Statistical Analysis 11
Data was analysed using SPSS 11 for Mac OS 10 (SPSS Inc., Chicago, 12
Illinois, www.SPSS.com). Semen profiles and nuclear DNA fragmentation 13 data from controls and diabetic men were compared using Student's t-test. 14 Sperm concentrations and total sperm output were normalised using a square 15 root transformation. To account for the non-Gaussian distribution of the 16 mitochondrial DNA data, the non-parametric Mann Whitney-U test was used 17 to compare median values for control and diabetic subjects. (Table I) . As expected, mean glycosyated haemoglobin was 10 significantly higher in the diabetic group. There was no significant difference 11 between groups in the mean age of subjects. Mean abstinence times did not 12 differ between the control and diabetic groups. Mean semen volume in 13 diabetic men was significantly less than for non-diabetic controls. However, no 14 significant differences were observed in sperm count, total sperm output, 15 percentage motility, or percentage normal morphology. 16
Nuclear DNA fragmentation of control and diabetic sperm
17 assessed by the Alkaline Comet assay 18 The mean percentage of fragmented sperm nDNA as determined by the 19
Comet assay was significantly higher in sperm from diabetic subjects (n=24) 20 compared to that from non-diabetic controls (n=23) (53%±3 vs. 32%±2; 21 p<0.0001) [ Figure 1 ]. Our group has previously reported an Intra assay 1 coefficient of variation less than 6% for this assay (Hughes et al. 1997) . 2
Number and size of mtDNA deletions in control and diabetic
The median number of mtDNA deletions was significantly higher in 5 sperm from diabetic subjects (n=23) when compared to controls (n=21) (4 [3-6 6] vs. 3 [1-4]; p<0.05) [ Figure 2a ]. None of the sperm from diabetic subjects 7 displayed wild-type mtDNA, compared with 10% of controls. Ninety-one 8 percent of diabetic men displayed more than two mtDNA deletions compared 9 to 67% of controls (p<0.05). The median size of mtDNA deletions did not differ 10 significantly between the two groups (7kb [6-7] vs. 7 [6-7]; p>0.05) [ Figure 2b ]. 11
Discussion 1
The rising incidence of DM worldwide will inevitably result in an 2 increased prevalence in men of reproductive age. Infertility is already a major 3 health problem in both the developed and developing world with up to 1 in 6 4 couples requiring specialist investigation or treatment in order to conceive 5 (Hull et al. 1985; Schmidt et al. 1995) . Disorders of sperm are thought to be 6 either causative or contributory in 40-50% of infertile couples (Thonneau et al. 7 1991; Sharlip et al. 2002) . Moreover, the last 50 years has seen an apparent 8 decline in semen quality (Carlsen et al. 1992) . The increasing incidence of 9 systemic diseases such as DM may further exacerbate this decline in male 10
fertility. 11
Previous studies have estimated the prevalence of type-1 DM in sub-12 fertile men at approximately 1% (Greenberg et al. 1978; Sexton et al. 1997) . 13
Based on the background prevalence of DM and male infertility in this age 14 group this figure was expected to be around 0.3% (Sexton et al. 1997) . 15
Despite this, our postal survey reinforces the fact that DM is not currently 16 seen as a particularly relevant issue in the assessment of male fertility. This 17 would suggest the need for a large-scale epidemiological study to investigate 18 the relationship between male fertility and DM. 19
Animal studies using rodent models of streptozotocin-induced DM have 20 demonstrated a reduction in sperm counts and quality (Ballester et al. 2004; 21 Amaral et al. 2006; Scarano et al. 2006 ). In addition, a marked reduction in 22 fecundity has been observed after as little as 15 days following the injection of 23 streptozotocin (Scarano et al. 2006 ). Other groups have reported similar 24 findings after longer periods of induced diabetes (2-6 months) (Frenkel et al. 1 1978; Cameron et al. 1990; Ballester et al. 2004 ). The associated reduction in 2 fertility is more pronounced when DM is induced in pre-pubertal animals 3 (Frenkel et al. 1978) . Furthermore, spontaneously occurring DM in the BB 4
Wistar rat, is also associated with a significant reduction in fertility (Murray et 5 al. 1983; Cameron et al. 1990 ) thus eliminating any possible confounding 6 effects of diabetogenic agents as a primary cause. These studies support the 7 hypothesis that DM impairs male reproductive function. 8
Studies of semen quality in diabetic men have, so far, been limited to the 9 use of conventional light microscopy. A reduction in all semen parameters 10 (semen volume, sperm count, motility and morphology) has been observed in 11 two studies of type-1 diabetics (Padron et al. 1984; Garcia-Diez et al. 1991) . 12
However, Handelsman and colleagues found only semen volume and total 13 sperm output to be significantly lower in diabetic men (Handelsman et al. 14 1985) . In a larger study of 100 type-1 and 314 type -2 diabetics (Ali et al. 15 1993) , the authors found an increase in sperm concentration and total sperm 16 output but a concomitant reduction in motility and no difference in sperm 17
morphology. Vignon et al. demonstrated higher sperm concentrations and 18
abnormal morphology with no difference in motility (Vignon et al. 1991) . Not 19 surprisingly, many of these diabetic men with normal semen parameters had 20 fathered children and the study concluded that DM, in itself, was not a cause 21 of sub-fertility. 22
A study of 54 diabetic men (9 type-1 diabetics) found the principal 23 abnormality to be a reduction in the forward motility of sperm (Dinulovic et al. 24 1990b) . In contrast, one report of sperm motility (Niven et al. 1995) , using 25 computer assisted image analysis, reported an increase in the linear 1 movement of sperm from diabetic men. This group postulated that DM could 2 even confer a minor advantage in terms of fertility, although the in vivo 3 significance of this finding was not clear. In all those studies demonstrating an 4 adverse effect of diabetes on semen parameters, poor metabolic control and 5 associated neuropathy have been shown to be important predictors of the 6 extent of impairment (Sexton et al. 1997) . 7
Conventional semen analysis remains core to the evaluation of male 8 fertility in the clinical setting. However, whilst the WHO reference values for 9 semen parameters are published and widely used, considerable controversy 10 exists as to the value of recommended 'normal' thresholds (Ombelet et al. 11 1997; Bonde et al. 1998; Chia et al. 1998; Guzick et al. 2001) . A man with an 12 apparently normal semen analysis may still be sub-fertile (Bonde et al. 1998; 13 Saleh et al. 2002) . In addition, large intra-individual variations occur over time 14 (Mallidis et al. 1991; World Health Organization 1999; Alvarez et al. 2003) . 15
Although we have observed a significant reduction in mean semen 16 volume in diabetic men, it still remains within the normal range set by the 17
World Health Organisation (World Health Organization 1999). In addition, we 18
have not found significant differences in any of the other conventional semen 19 parameters. It is our contention, that the significant differences lie at a 20 'molecular' and not a 'cellular' level. 21
In view of the limitations of conventional semen analysis, we determined 22 sperm nDNA and mtDNA status, as molecular biomarkers of fertility potential. 23
The need for the evaluation of sperm DNA quality to be introduced into the 24 clinical setting has been acknowledged (Perreault et al. 2003; Aitken 2006) . 25
These tests of 'genetic integrity' provide additional independent information on 1 sperm quality (Trisini et al. 2004) , identifying abnormalities that are not 2 apparent in conventional semen profiles (Saleh et al. 2002) . However, these 3 tests have not yet gained clinical popularity as they are laborious, time 4 consuming and relatively expensive. In addition, useful clinical thresholds 5 have yet to be established for many of these techniques (Perreault et al. 6 2003) . 7
This is the first report to our knowledge of sperm nuclear and 8 mitochondrial DNA quality in men with diabetes. Our study identifies important 9 evidence of increased nDNA fragmentation and mtDNA deletions in sperm 10 from diabetic men. These findings are concerning, as they may have 11 implications for the fertility, risk of miscarriage and health of the children of 12 diabetic men. 13
The relationship between genomic integrity and male fertility has been 14 the subject of intense research over the past decade (O'Brien et al. 2005; 15 Evenson et al. 2006 ). Numerous reports have demonstrated an increase in 16 sperm DNA damage in infertile men (Kodama et al. 1997; Evenson et al. 17 1999; Spano et al. 2000; Zini et al. 2001 ). Furthermore, sperm DNA has been 18 shown to be predictive of the time taken to achieve a pregnancy (Loft et al. 19 2003) . 20
Damage to sperm DNA does not necessarily preclude fertilization 21 (Aitken et al. 1998; Ahmadi et al. 1999a Ahmadi et al. , 1999b . The oocyte has a limited 22 ability to repair damaged sperm DNA (Matsuda et al. 1989; Genesca et al. 23 1992) and fragmentation beyond this threshold may result in increased rates 24 of embryonic failure and pregnancy loss (Ahmadi et al. 1999b ). In the context 25 of spontaneous conception, sperm DNA quality has been found to be poorer 1 in couples with a history of spontaneous miscarriage (Carrell et al. 2003a; 2 Carrell et al. 2003b) . 3 Perhaps more worryingly, increased sperm DNA damage has been 4 implicated in the future health of resulting offspring (Brinkworth 2000; Aitken 5 et al. 2003a; Aitken 2004) . Children of men who smoke, and thus have 6 increased levels of oxidative sperm DNA damage (Fraga et al. 1996) , are 7 more likely to suffer from childhood cancers, particularly leukaemia and 8 lymphoma (Ji et al. 1997) . In one series, 14% of all childhood cancers were 9 linked to paternal smoking (Sorahan et al. 1997) . Thus, sperm DNA damage 10 in men can have significant and long lasting effects, which are not simply 11 limited to male infertility itself but perpetuated in future generations to the 12 detriment of their offspring. 13
A variety of approaches exists for the assessment of sperm nDNA. We 14 used the Alkaline COMET assay, previously modified for use with sperm by 15 this group among others (Hughes et al. 1997; Donnelly et al. 1999) . The 16
COMET assay is a simple, reliable and reproducible technique to measure 17 DNA fragmentation in individual sperm (Hughes et al. 1997) . Various versions 18 of this assay exist, however, the alkaline COMET assay allows for the widest 19 detection of DNA damage (Hartmann et al. 2003) . Assessment of sperm DNA 20 quality using this method has been shown to be predictive of pregnancy rates 21 in assisted conception (Morris et al. 2002; Lewis et al. 2004) . 22
Various studies have shown that fertility declines when sperm DNA 23 fragmentation measured by the sperm chromatin structure assay (SCSA) is 24 elevated: >30% (Evenson et al. 1999 ) >40% (Spano et al. 2000) . In addition, 25 the authors of a study employing Terminal dUTP nick-end labelling (TUNEL 1 assay), showed that by using a threshold of 20% fragmentation, a specificity 2 of 89% and sensitivity of 97% for distinguishing between fertile and infertile 3 men could be achieved (Sergerie et al. 2005) . These studies, amongst others, 4 reinforce the value of these tests assessing the genomic integrity of sperm in 5 the prediction of male fertility potential (Agarwal et al. 2005) . 6
The aetiology of sperm DNA damage is multi-factorial (Agarwal et al. 7 2003; O'Brien et al. 2005) , including factors such as deficient chromatin 8 packing (Manicardi et al. 1995) , abortive apoptosis (Shen et al. 2002) , 9 environmental pollutants (Aitken 2004) and increased oxidative stress (Aitken 10 et al. 1994) . Sperm are particularly susceptible to damage by excessive levels 11 of oxidative stress, due to their high content of unsaturated fatty acids and 12 relative lack of cytosolic antioxidant protection (Aitken et al. 2003b) . The 13 absence of DNA repair mechanisms further exacerbates this effect. 14 The importance of mtDNA quality in male fertility has also been 15 increasingly recognised (Cummins et al. 1994; St John et al. 2005) , with 16 mtDNA deletions being associated with impaired sperm motility and fertility 17 (Lestienne et al. 1997; Kao et al. 1998; Spiropoulos et al. 2002) . MtDNA is 18 subject to much greater oxidative stress than nDNA due, in part, to its close 19 proximity to respiratory chain complexes, which produce reactive oxygen 20 species as a by-product of oxidative phosphorylation (Van Houten et al. 21 2005) . The lack of histone protection (Shoffner et al. 1994 ) also renders it 22 more vulnerable to oxidative damage. Rapid replication, inefficient proof 23 reading and limited repair mechanisms result in mutation rates that are 10-24 100 times higher than those found in nDNA (Kao et al. 1998 ). Furthermore, 25 damage to mtDNA in sperm has been shown to occur at much lower levels of 1 oxidative stress than nDNA (Bennetts et al. 2005 ) reinforcing its importance 2 as a sensitive indicator of 'sperm health' (Lewis et al. 2004) . 3
Oxidative stress is also recognised to be an important factor in the 4 pathogenesis of many of the chronic complications of diabetes (Giugliano et 5 al. 1996; Nishikawa et al. 2000; Piconi et al. 2003; Wiernsperger 2003) . 6
Indeed, DNA damage in the diabetic vasculature is an important stimulus for 7 the initiation of mechanisms resulting in endothelial dysfunction and ensuing 8 vasculopathy. We hypothesise that the observed increase in sperm DNA 9 damage is a further complication of diabetes in men whose developing sperm 10 are exposed to supra-physiological levels of glucose and, therefore, oxidative 11
insult. 12
In this study, control subjects were recruited from men attending for a 13 semen analysis as part of a general infertility workup. These men were 14 chosen due to the practical difficulty encountered in recruiting men of recent 15 proven fertility. It could be argued that the current control group is not 16 representative of the general population. However, given the association 17 between infertility and both nDNA & mtDNA damage, one would reasonably 18 expect these men, if anything, to be biased towards a higher level of nuclear 19 DNA fragmentation (Gandini et al. 2000; Spano et al. 2000; Zini et al. 2001; 20 Saleh et al. 2002; Sergerie et al. 2005 ) than their proven fertile counterparts. 21
Therefore, any significant differences demonstrated between diabetic men 22 and this control group would be of even greater significance if compared to a 23 fertile population. 24
Conclusion 1
The effects of diabetes on human male reproductive function have, thus 2 far, been largely neglected beyond concerns about impotence. Whilst this 3 study shows that conventional semen parameters of diabetic men do not differ 4 significantly from control subjects, their sperm do have increased levels of 5 nDNA and mtDNA damage. From a clinical perspective this is important, 6 particularly given the overwhelming evidence that sperm DNA damage 7 impairs male fertility and reproductive health. Further studies characterising 8 the precise nature of this damage, the aetiological mechanisms behind it and 9 evaluating its clinical significance are required. 
